Mereo BioPharma Group plc - Sponsored ADR MREO
0.37
0.03
8.82%
as of 25 Sep
- Market cap
- $54.9M
- P/E
- 0.0×
Follow MREO
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
5.31 | 5.86 | 9.53 | 8.09 | |
Current Ratio |
5.88 | 6.48 | 10.46 | 8.71 | |
Net Debt/EBITDA |
4.39 | 4.21 | 5.37 | 4.62 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.74% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.01 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.86 | 0.64 | 1.05 | 1.04 | |
Capex/Depreciation |
0.00 | (1.75) | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.01 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.04) | (0.03) | (0.05) | (0.05) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.04) | (0.03) | (0.05) | (0.05) | |
Cash per Share |
0.19 | 0.23 | 0.26 | 0.30 | |
Shareholders Equity per Share |
0.18 | 0.21 | 0.26 | 0.29 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.18 | 0.21 | 0.26 | 0.29 | |
Free Cash Flow |
(6.04) | (4.61) | (7.68) | (7.31) | |
Working Capital |
27.72 | 33.86 | 40.72 | 46.39 | |
Capital Expenditures |
0.00 | (0.30) | 0.00 | 0.00 | |
Net Current Asset Value |
27.34 | 33.47 | 40.02 | 45.40 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
1.13 | 3.08 | 1.89 | 1.31 | |
Average Assets |
48.67 | 54.47 | 61.15 | 71.17 | |
Average Common Equity |
41.41 | 47.07 | 50.94 | 59.57 |
Columns are period end dates